Quote For Genzyme Corporation
Genzyme Corporation (GENZ.O) (Nasdaq)
sector: Healthcare ·
industry: Biotechnology ·
$51.52
25 Nov 2009
+2.26%
$50.38
$50.81
3,283,069
$51.62
$50.59
$73.75
$47.09
0.30
6,350,807
News
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Termeer, Henri | Chairman of the Board, President, Chief Executive Officer | 13,773,782 |
| Wyzga, Michael | Chief Financial Officer, Executive Vice President - Finance | 3,019,202 |
| Wirth, Peter | Executive Vice President - Legal and Corporate Development, Secretary | 3,246,359 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $13,618.14 |
| Shares Outstanding (Mil.) | 270.31 |
| Float (Mil.) | 262.20 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 2.26 |
| Current Ratio | 2.55 |
| LT Debt/Equity | 1.55 |
| Total Debt/Equity | 1.66 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 28.73 |
| Price/Sales(TTM) | 2.96 |
| Price/Book(TTM) | 1.76 |
| Price/Cash Flow(TTM) | 14.90 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $1.80 |
| Sales(TTM) | $16.59 |
| Book Value(MRQ) | $28.70 |
| Cash Flow(TTM) | $3.29 |
| Cash(MRQ) | $3.20 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 6.54 |
| Return on Assets(TTM) | 5.01 |
| Return on Investment(TTM) | 5.78 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 71.65 |
| Operating Margin(TTM) % | 13.98 |
| Profit Margin(TTM) % | 10.54 |
Commodities
| Commodity | Last | Pct Chg | Trade Date/Time |
|---|---|---|---|
| Oil | 78.01 | -0.55% | 11/26 08:05 IST |
| Gold | 1193.3 | +0.53% | 11/26 07:45 IST |
